Skip to content

Effects of Dietary Fiber on Gastrointestinal Function

A Double-blind, Randomized, Crossover Trial to Assess the Gastrointestinal Tolerability of a Dietary Fiber Ingredient in Healthy Men and Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01495182
Enrollment
26
Registered
2011-12-19
Start date
2011-12-31
Completion date
2012-12-31
Last updated
2016-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Health

Keywords

Dietary fiber, Gastrointestinal toleration, Fecal weight

Brief summary

The purpose of the study will be to assess the gastrointestinal effects of a dietary fiber in healthy, adult volunteers.

Detailed description

The study is a blinded, cross-over design with subjects completing three, two-week treatment periods, separated by two, two-week washouts. Volunteers will consume a dietary fiber for two of the treatment periods at two dose levels. The fiber will be added to foods and dispensed to subjects to be consumed twice a day during each treatment period. During the control period, subjects will receive the same study foods, but with no added fiber. Major outcomes will include fecal weight, and responses to questionnaires that assess fecal characteristics, bowel habits and gastrointestinal tolerability.

Interventions

OTHERDietary fiber

A proprietary fiber will be given to subjects

Sponsors

Ingredion Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 54 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy men and women * age 18 - 54 years * BMI \< 30 kg/m2

Exclusion criteria

* presence of GI or other serious diseases known to affect GI function * recent use of antibiotics * very high fiber intake * use of medications known to affect GI function * presence of allergies to study foods

Design outcomes

Primary

MeasureTime frameDescription
Gastrointestinal tolerabilitysubjects will report weekly for 6 weeksQuestionnaire to assess symptoms such as nausea, bloating, and flatulence

Secondary

MeasureTime frameDescription
Fecal outputsubjects will collect fecal output for 12 days within a six-week periodFecal weight and stool characteristics will be measured

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026